Explore 4 court opinions on Obviousness Type Double Patenting. AI-powered plain English summaries, key holdings, and legal analysis.
4 recent cases analyzed in this topic area.
Settlement Agreement Unenforceable Due to Lack of Mutual Assent
Colage v. Collins, decided by Federal Circuit on December 3, 2025, resulted in a defendant win outcome. The case concerns the enforceability of a settlement agreement in a patent infringement dispute....
CAFC Affirms Obviousness-Type Double Patenting Invalidity of Merck MS Drug Patent
Merck Serono S.A. v. Hopewell Pharma Ventures, Inc., decided by Federal Circuit on October 30, 2025, resulted in a defendant win outcome. The core dispute involved Merck's claim that Hopewell infringe...
Federal Circuit Affirms Patent Infringement for Schizophrenia Treatment
Janssen Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc., decided by Federal Circuit on July 8, 2025, resulted in a plaintiff win outcome. The core dispute centered on whether Teva Pharmaceutic...
CAFC Affirms Biosimilar Infringement Finding for Ruxolitinib Patents
Incyte Corporation v. Sun Pharmaceutical Industries, Ltd., decided by Federal Circuit on May 7, 2025, resulted in a plaintiff win outcome. The core dispute centered on whether Sun Pharma's proposed bi...